Benitec Biopharma Inc

BNTCNASDAQ · USD
9.55USD-0.09 (-0.94%)
315

Benitec Biopharma Inc (BNTC) Covered Calls

As of September 24, 2026, BNTC has 7 covered call opportunities in the coming three months. Return ranges from 2.7 to 53.6% until expiration. Annualized return ranges from 17.3 to 95.5%. The nearest expiration is October 16, 2026. Maximum potential profit is $527.

Read more

Running BNTC covered calls helps you generate consistent income from Benitec Biopharma Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Benitec Biopharma Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best BNTC covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if BNTC stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling BNTC covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Benitec Biopharma Inc covered call is worth writing.

Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.

Income-focused investors, long-term BNTC holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling BNTC covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Benitec Biopharma Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile24.21% Subdued
  • Market cap (M$)336
  • 52 weeks high-42.48%
  • 52 weeks low1.58%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$21.00
    153.09% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-13
  • P/E—
  • Future P/E—
  • EPS (ttm)-1.09
  • EPS growth next 5 years-12.09%

As of September 24, 2026

2027-04-1620515.0052.590.104.90527.0053.6195.45-1.02+0.5304.80
2027-01-1511412.5027.160.104.90277.0028.1890.22-1.02+0.56134.80
2027-04-1620512.5027.160.504.90317.0032.2557.42-5.09+0.5804.40
2026-10-162310.001.730.104.9027.002.7543.59-1.02+0.6244.80
2027-01-1511410.001.730.504.9067.006.8221.82-5.09+0.64104.40
2027-04-1620510.001.730.804.9097.009.8717.57-8.14+0.6514.10
2026-11-205810.001.730.104.9027.002.7517.29-1.02+0.6204.80

As of September 24, 2026

Sell covered calls with the data behind you

Find the best BNTC covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial